Effect of human albumin infusion rate on neonatal capillary leak syndrome: a randomized controlled trial

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100050597

Enrollment

Unknown

Registered

2021-09-01

Start date

2021-08-24

Completion date

Unknown

Last updated

2022-05-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neonatal capillary leak syndrome

Interventions

Experimental group1:rapid rate infusion

Experimental group2:General infusion group

Control Group:General traditional treatment

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Children who met the diagnostic criteria for CLS and were treated with a human blood albumin infusion

Exclusion criteria

Exclusion criteria: Patients with a hospital stay of less than 48 hours and incomplete clinical data.

Design outcomes

Primary

Measure	Time frame
28 day-mortality;	—

Countries

China

Contacts

Public ContactWei Hong

Children's Hospital of Chongqing Medical University

waehong@yahoo.com+86 15310156407

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026